Back to News
Market Impact: 0.12
Nuritas nombra a Kees Kruythoff, expresidente de Unilever Norteamérica, presidente del Consejo de Dirección
Source: PR Newswire
Healthcare & BiotechManagement & GovernanceCompany Fundamentals
Nuritas announced the addition of a biotechnology industry veteran with 30 years of experience, citing expertise in global scaling and commercialization. The leadership appointment supports the bioactive-peptide company's growth ambitions, but the truncated release provides no financial terms, operating targets, or product-specific milestones.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
More News
- Here’s the ‘core economic flaw’ in the AI bull case as stock and bond trades unravel, according to a top economist
- Biotech stocks are surging. How investors can play the new drug innovation boom
- Braskem creditors, shareholders near deal on $11bn debt restructuring
- Instacart reportedly discussed selling itself with DoorDash and Uber
- Nvidia's role as AI financier faces first big test as neoclouds take market hit
- Trump set to announce plan by Audi to build a U.S. factory in Georgia, source says